Alistair Duncan
Founder at viDA Therapeutics, Inc.
Profile
Alistair Duncan is the founder of Chromos Molecular Systems, Inc. (founded in 1998) and.
viDA Therapeutics, Inc. (founded in 2008).
He holds the title of President & Chief Executive Officer at Chromos Molecular Systems, Inc. in 2008 and President, Chief Executive Officer & Director at viDA Therapeutics, Inc. He is currently a Director at Metro Vancouver Properties Corp.
Mr. Duncan previously worked as a Director at MIGENIX, Inc. from 2004 to 2010, Director at Global Gaming Technologies Corp.
from 2010 to 2012, and Director at BC Technology Industry Association and Michael Smith Foundation for Health Research.
He also held the position of Principal at Ernst & Young LLP, Chief Financial Officer at Agrisoma Biosciences, Inc., and was a Member of The Institute of Chartered Accountants of British Columbia.
Mr. Duncan completed his undergraduate degree at the University of British Columbia.
Alistair Duncan active positions
Companies | Position | Start |
---|---|---|
viDA Therapeutics, Inc.
viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Founder | 31/12/2007 |
Metro Vancouver Properties Corp.
Metro Vancouver Properties Corp. Real Estate DevelopmentFinance Metro Vancouver Properties Corp. provides real estate brokerage services. The company is headquartered in Vancouver, Canada. | Director/Board Member | - |
Former positions of Alistair Duncan
Companies | Position | End |
---|---|---|
The Institute of Chartered Accountants of British Columbia | Corporate Officer/Principal | 21/10/2012 |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Director/Board Member | 23/03/2010 |
Chromos Molecular Systems, Inc.
Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Founder | 15/04/2008 |
Agrisoma Biosciences, Inc.
Agrisoma Biosciences, Inc. Chemicals: SpecialtyProcess Industries Agrisoma Biosciences, Inc. provides crop technology for biofuel and renewable energy solutions. Its crop improvement technologies include proprietary breeding, proprietary tissue culture and haploidy, molecular markers and genetic mapping and advanced crop improvement technologies. The company was founded by Steven Fabijanski and Tom Mamic in 2001 and is headquartered in Gatineau, Canada. | Director of Finance/CFO | - |
GLOBAL GAMING TECHNOLOGIES CORP. | Director/Board Member | - |
Training of Alistair Duncan
University of British Columbia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
GLOBAL GAMING TECHNOLOGIES CORP. | Finance |
Private companies | 9 |
---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
Michael Smith Foundation for Health Research
Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Miscellaneous |
BC Technology Industry Association | |
viDA Therapeutics, Inc.
viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Chromos Molecular Systems, Inc.
Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Health Technology |
Agrisoma Biosciences, Inc.
Agrisoma Biosciences, Inc. Chemicals: SpecialtyProcess Industries Agrisoma Biosciences, Inc. provides crop technology for biofuel and renewable energy solutions. Its crop improvement technologies include proprietary breeding, proprietary tissue culture and haploidy, molecular markers and genetic mapping and advanced crop improvement technologies. The company was founded by Steven Fabijanski and Tom Mamic in 2001 and is headquartered in Gatineau, Canada. | Process Industries |
Metro Vancouver Properties Corp.
Metro Vancouver Properties Corp. Real Estate DevelopmentFinance Metro Vancouver Properties Corp. provides real estate brokerage services. The company is headquartered in Vancouver, Canada. | Finance |
The Institute of Chartered Accountants of British Columbia | Commercial Services |
- Stock Market
- Insiders
- Alistair Duncan